CAN-ASC is a Canada-wide consortium of researchers and clinician scientists. We collaborate with international networks from academia and industry to develop consensus-driven, standardized and validated operating procedures (SOPs) for human immunology research.
The Canucks for Kids Fund Childhood Diabetes Laboratories aim to improve the lives of children with diabetes by advancing knowledge of type 1 and type 2 diabetes, through innovative and multi-disciplinary basic and clinical diabetes research.
Researchers with the Michael Cuccione Childhood Cancer Research Program embrace one goal: to save children’s lives, while improving their health and quality of life through every phase of treatment and recovery.
A new study from BC Children’s, UBC and an international team of researchers published in the New England Journal of Medicine is the first to identify a rarely-seen type of DNA mutation as the cause of an inherited metabolic disorder.
A recent study from Dr. Pascal Lavoie provides important insights into why preterm babies are more vulnerable to infections than babies born at term. This work could lead to the development of new treatments that jump-start their immune systems.
Dr. Michael Kobor and Dr. Yvonne Lamers, are leading two new international projects investigating the relationship between diet, the epigenome and health thanks to funding from the Canadian Institutes of Health Research (CIHR).
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.